Concepedia

Weiyuan Ma

WM

Statistics

Publications

17

Citations

490

H-Index

14

Active since

2013

Affiliations

Second Hospital of Hebei Medical University(Current)

Hebei Medical University

Qilu Hospital of Shandong University

Shandong University

Jinan Central Hospital

Weiyuan Ma is an author at Second Hospital of Hebei Medical University specializing in medicine, molecular oncology, and oncology.

Publications per year

2013–2021

17

Publications

17

Quercetin alleviates hyperthyroidism‐induced liver damage via Nrf2 Signaling pathway

Pengxin Zhao, Zhigang Hu, Weiyuan Ma et al. · BioFactors · 2020 · 46 citations

Medicine, Endocrinology, Pharmacology +14

MiR-370 functions as oncogene in melanoma by direct targeting pyruvate dehydrogenase B

Shufang Wei, Weiyuan Ma · Biomedicine & Pharmacotherapy · 2017 · 44 citations

Medicine, Molecular Biology, Oncology +14

Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4

Pengxin Zhao, Weiyuan Ma, Zhigang Hu et al. · Journal of Endocrinological Investigation · 2018 · 43 citations

Medicine, Molecular Biology, Oncology +14

<scp>IL</scp>‐22‐induced miR‐122‐5p promotes keratinocyte proliferation by targeting Sprouty2

Meng Jiang, Weiyuan Ma, Yumei Gao et al. · Experimental Dermatology · 2016 · 41 citations

Life Sciences, Dermatology, Molecular Biology +17

Metformin inhibits proliferation and proinflammatory cytokines of human keratinocytes <i> <b>in vitro</b> </i> via mTOR-signaling pathway

Ying Liu, Fan Yang, Weiyuan Ma et al. · Pharmaceutical Biology · 2015 · 40 citations · Full text

Medicine, Dermatology, Pharmacology +17

1–5 of 17